Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Medtronic Cardiac Ablation Solutions
- Study ID
- NCT07585968
- Status
- Recruiting
Conditions
- Ventricular Tachycardia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sphere-9 Catheter with the Affera Mapping and Ablation System — DEVICEAdult subjects with ventricular tachycardia will be enrolled and undergo ablation with the Sphere-9 Catheter with the Affera Mapping and Ablation System.
Study Details
Sphere VT is a prospective, multi-center, single-arm, unblinded pivotal clinical study. Adult subjects with recurrent, sustained, monomorphic ventricular tachycardia (MMVT) due to prior myocardial infarction (MI) will be enrolled and treated with the Sphere-9 Catheter and Affera Ablation System.
Key Dates
- First listed
- May 14, 2026
- Start date
- Aug 17, 2026
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 260 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Ventricular tachycardia catheter ablationAblation using the Sphere-9 Catheter with the Affera Mapping and Ablation System
Primary Outcome Measure
Primary Safety [ Time Frame: As applicable, within 7 days or 3 months after the index ablation procedure ]
Central Contacts
- Josh Treadway817-412-0608
- Mckenna Jones720-837-3089
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Atrium Health Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157-0001 | |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210-1240 | |
| Texas Cardiac Arrhythmia Research Foundation | Austin | Texas | 78705-1852 |
Find similar trials in Winston-Salem, NC
Related Studies
- IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation RegistryEnrolling By Invitation · University of California, Los Angeles · Phoenix, Arizona
- Venous Ethanol for Ventricular TachycardiaPHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas
- Pulsed Field Ablation for Post-Infarction Ventricular TachycardiaRecruiting · Pasquale Santangeli · Cleveland, Ohio
- Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) StudyRecruiting · AtaCor Medical, Inc. · Scottsdale, Arizona